The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.

FIRM Approaches in Complex Patients: A US Private Practice Perspective

Approaches for Focal Impulse and Rotor Mapping in Complex Patients: A US Private Practice Perspective1

Patent Characteristics:

56 consecutive patients with a mean follow up of 7.7±3.0 months.
The majority of patients consisted of persistent AF (34%) or long-standing persistent AF (43%), large atria, and/or complex co-morbidities.

Study Findings:

FIRM mapping revealed rotors/focal sources in all patients.

  • 62.5% (35/56) of patients had right atrial rotors.
  • Patients with enlarged atrial volumes or who have failed a previous AF ablation have a significantly higher number of right atrial rotors.

Finally, FIRM mapping was added without impacting the workflow of the AF ablation procedure, as evidenced by a total procedure time (221 min.) that is similar to findings reported in other studies.

Copies of published articles and RhythmView® labeling are available on request. Any questions regarding the publications or clinical use of RhythmView Workstation should be directed to our medical affairs team.

  1. Haroon Rashid, MD, FACC and Amy Sweeney, RN, BSN. Approaches for Focal Impulse and Rotor Mapping in Complex Patients: A US Private Practice Perspective. Journal of Innovations Cardiac Rhythm Management. 6 (2015), 2193–2198
  2. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–1822